I mean they both have worked with BioAmber and are no stranger to the marketplace...
But wouldn't it make sense that if one were to pursue being #1 in that field, and the opportunity was there at a reasonable price, would you just finance the debt or make an offer to buy it out lock stock and barrel?
And at a fair market value based on the products market not the stock pricing. What would it be worth to them?
That is all that I am bringing to the table...
If I were a $100 pps company, buying a smaller company but #1 in their industry for $5 - $10... might be worth the gamble.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.